vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and KFORCE INC (KFRC). Click either name above to swap in a different company.
KFORCE INC is the larger business by last-quarter revenue ($330.4M vs $270.7M, roughly 1.2× BALCHEM CORP). BALCHEM CORP runs the higher net margin — 14.9% vs 2.4%, a 12.5% gap on every dollar of revenue. On growth, BALCHEM CORP posted the faster year-over-year revenue change (8.1% vs 0.1%). BALCHEM CORP produced more free cash flow last quarter ($33.8M vs $-7.4M). Over the past eight quarters, BALCHEM CORP's revenue compounded faster (7.5% CAGR vs -3.7%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
Kforce Inc. is a professional staffing and solutions firm headquartered in the United States. It provides skilled professional placements and specialized workforce solutions primarily across technology, finance & accounting, and healthcare segments, serving a wide range of mid-sized to large enterprise clients nationwide.
BCPC vs KFRC — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.7M | $330.4M |
| Net Profit | $40.3M | $7.9M |
| Gross Margin | — | 27.3% |
| Operating Margin | 20.5% | 3.6% |
| Net Margin | 14.9% | 2.4% |
| Revenue YoY | 8.1% | 0.1% |
| Net Profit YoY | 8.7% | -2.7% |
| EPS (diluted) | $1.25 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $270.7M | $330.4M | ||
| Q4 25 | $263.6M | $332.0M | ||
| Q3 25 | $267.6M | $332.6M | ||
| Q2 25 | $255.5M | $334.3M | ||
| Q1 25 | $250.5M | $330.0M | ||
| Q4 24 | $240.0M | $343.8M | ||
| Q3 24 | $239.9M | $353.3M | ||
| Q2 24 | $234.1M | $356.3M |
| Q1 26 | $40.3M | $7.9M | ||
| Q4 25 | $39.2M | $5.2M | ||
| Q3 25 | $40.3M | $11.1M | ||
| Q2 25 | $38.3M | $10.4M | ||
| Q1 25 | $37.1M | $8.1M | ||
| Q4 24 | $33.6M | $11.1M | ||
| Q3 24 | $33.8M | $14.2M | ||
| Q2 24 | $32.1M | $14.2M |
| Q1 26 | — | 27.3% | ||
| Q4 25 | 35.6% | 27.2% | ||
| Q3 25 | 35.7% | 27.7% | ||
| Q2 25 | 36.4% | 27.1% | ||
| Q1 25 | 35.2% | 26.7% | ||
| Q4 24 | 36.0% | 27.0% | ||
| Q3 24 | 35.6% | 27.9% | ||
| Q2 24 | 35.5% | 27.8% |
| Q1 26 | 20.5% | 3.6% | ||
| Q4 25 | 19.8% | 2.6% | ||
| Q3 25 | 20.4% | 4.5% | ||
| Q2 25 | 20.1% | 4.5% | ||
| Q1 25 | 20.4% | 3.5% | ||
| Q4 24 | 19.8% | 4.5% | ||
| Q3 24 | 20.0% | 5.3% | ||
| Q2 24 | 19.6% | 5.5% |
| Q1 26 | 14.9% | 2.4% | ||
| Q4 25 | 14.9% | 1.6% | ||
| Q3 25 | 15.1% | 3.3% | ||
| Q2 25 | 15.0% | 3.1% | ||
| Q1 25 | 14.8% | 2.5% | ||
| Q4 24 | 14.0% | 3.2% | ||
| Q3 24 | 14.1% | 4.0% | ||
| Q2 24 | 13.7% | 4.0% |
| Q1 26 | $1.25 | $0.46 | ||
| Q4 25 | $1.21 | $0.29 | ||
| Q3 25 | $1.24 | $0.63 | ||
| Q2 25 | $1.17 | $0.59 | ||
| Q1 25 | $1.13 | $0.45 | ||
| Q4 24 | $1.03 | $0.60 | ||
| Q3 24 | $1.03 | $0.75 | ||
| Q2 24 | $0.98 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $1.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $117.4M |
| Total Assets | $1.7B | $384.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $72.9M | $1.3M | ||
| Q4 25 | $74.6M | $2.1M | ||
| Q3 25 | $65.1M | $1.3M | ||
| Q2 25 | $65.4M | $2.5M | ||
| Q1 25 | $49.9M | $444.0K | ||
| Q4 24 | $49.5M | $349.0K | ||
| Q3 24 | $73.7M | $127.0K | ||
| Q2 24 | $63.7M | $110.0K |
| Q1 26 | $1.3B | $117.4M | ||
| Q4 25 | $1.3B | $124.6M | ||
| Q3 25 | $1.3B | $132.1M | ||
| Q2 25 | $1.3B | $134.4M | ||
| Q1 25 | $1.2B | $138.0M | ||
| Q4 24 | $1.1B | $154.6M | ||
| Q3 24 | $1.2B | $167.4M | ||
| Q2 24 | $1.1B | $166.6M |
| Q1 26 | $1.7B | $384.8M | ||
| Q4 25 | $1.7B | $365.6M | ||
| Q3 25 | $1.7B | $374.2M | ||
| Q2 25 | $1.7B | $373.6M | ||
| Q1 25 | $1.6B | $368.2M | ||
| Q4 24 | $1.6B | $357.8M | ||
| Q3 24 | $1.6B | $369.9M | ||
| Q2 24 | $1.6B | $362.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $40.1M | — |
| Free Cash FlowOCF − Capex | $33.8M | $-7.4M |
| FCF MarginFCF / Revenue | 12.5% | -2.2% |
| Capex IntensityCapex / Revenue | 2.3% | 1.0% |
| Cash ConversionOCF / Net Profit | 0.99× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $43.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $40.1M | — | ||
| Q4 25 | $67.3M | $19.7M | ||
| Q3 25 | $65.6M | $23.3M | ||
| Q2 25 | $47.3M | $18.4M | ||
| Q1 25 | $36.5M | $249.0K | ||
| Q4 24 | $52.3M | $21.8M | ||
| Q3 24 | $51.3M | $31.0M | ||
| Q2 24 | $45.0M | $20.9M |
| Q1 26 | $33.8M | $-7.4M | ||
| Q4 25 | — | $16.7M | ||
| Q3 25 | — | $19.8M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $-3.9M | ||
| Q4 24 | — | $20.9M | ||
| Q3 24 | — | $27.5M | ||
| Q2 24 | — | $17.8M |
| Q1 26 | 12.5% | -2.2% | ||
| Q4 25 | — | 5.0% | ||
| Q3 25 | — | 6.0% | ||
| Q2 25 | — | 4.3% | ||
| Q1 25 | — | -1.2% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | — | 5.0% |
| Q1 26 | 2.3% | 1.0% | ||
| Q4 25 | — | 0.9% | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | — | 0.9% |
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.72× | 3.82× | ||
| Q3 25 | 1.63× | 2.11× | ||
| Q2 25 | 1.23× | 1.76× | ||
| Q1 25 | 0.98× | 0.03× | ||
| Q4 24 | 1.56× | 1.97× | ||
| Q3 24 | 1.52× | 2.18× | ||
| Q2 24 | 1.40× | 1.48× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
